Published in Neurology on January 27, 2009
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Timing of onset of cognitive decline: results from Whitehall II prospective cohort study. BMJ (2012) 5.26
Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics. PLoS One (2011) 2.30
Trends in the incidence and prevalence of Alzheimer's disease, dementia, and cognitive impairment in the United States. Alzheimers Dement (2011) 2.26
Changing perspectives regarding late-life dementia. Nat Rev Neurol (2009) 2.04
The association between blood pressure and incident Alzheimer disease: a systematic review and meta-analysis. Epidemiology (2011) 2.01
Mediterranean diet and cognitive function in older age. Epidemiology (2013) 1.85
Red blood cell ω-3 fatty acid levels and markers of accelerated brain aging. Neurology (2012) 1.81
Predictive utility of the Framingham general cardiovascular disease risk profile for cognitive function: evidence from the Whitehall II study. Eur Heart J (2011) 1.79
A novel Aβ-fibrinogen interaction inhibitor rescues altered thrombosis and cognitive decline in Alzheimer's disease mice. J Exp Med (2014) 1.51
Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann Neurol (2010) 1.32
Frontal lobe white matter hyperintensities and neurofibrillary pathology in the oldest old. Neurology (2010) 1.22
Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Dis Assoc Disord (2014) 1.21
Accelerated progression from mild cognitive impairment to dementia in people with diabetes. Diabetes (2010) 1.18
Developmental aspects of the intracerebral microvasculature and perivascular spaces: insights into brain response to late-life diseases. J Neuropathol Exp Neurol (2011) 1.17
Effects of hypoperfusion in Alzheimer's disease. J Alzheimers Dis (2011) 1.13
Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel. Neuroepidemiology (2009) 1.12
The human frontal lobes and frontal network systems: an evolutionary, clinical, and treatment perspective. ISRN Neurol (2013) 1.09
Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly. Brain (2015) 1.09
Inflammation induced by infection potentiates tau pathological features in transgenic mice. Am J Pathol (2011) 1.07
Long-term adherence to the Mediterranean diet is associated with overall cognitive status, but not cognitive decline, in women. J Nutr (2013) 1.07
Dementia prevention: current epidemiological evidence and future perspective. Alzheimers Res Ther (2012) 1.07
Prevalence and pattern of cognitive impairment in rural and urban populations from Northern Portugal. BMC Neurol (2010) 1.05
Impaired glycemia increases disease progression in mild cognitive impairment. Neurobiol Aging (2013) 1.05
Treatment of cardiovascular risk factors to prevent cognitive decline and dementia: a systematic review. Vasc Health Risk Manag (2010) 1.04
Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. PLoS One (2013) 1.03
Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review. J Cereb Blood Flow Metab (2013) 1.03
DHA may prevent age-related dementia. J Nutr (2010) 1.02
Trends in the prevalence of dementia in Japan. Int J Alzheimers Dis (2012) 1.01
White matter predictors of cognitive functioning in older adults. J Int Neuropsychol Soc (2012) 0.98
Mechanisms of oligodendrocyte regeneration from ventricular-subventricular zone-derived progenitor cells in white matter diseases. Front Cell Neurosci (2013) 0.94
Is Alzheimer's disease a systemic disease? Biochim Biophys Acta (2014) 0.92
Role of amyloid peptides in vascular dysfunction and platelet dysregulation in Alzheimer's disease. Front Cell Neurosci (2015) 0.91
Association of chronic obstructive pulmonary disease with cognitive decline in very elderly men. Dement Geriatr Cogn Dis Extra (2012) 0.91
Dietary fatty acids and the aging brain. Nutr Rev (2010) 0.91
Stroke genetics: prospects for personalized medicine. BMC Med (2012) 0.90
Ischemic brain injury in cerebral amyloid angiopathy. J Cereb Blood Flow Metab (2016) 0.89
New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy. Front Aging Neurosci (2014) 0.89
Impact of cerebrovascular disease on cognitive function in HIV-infected patients. J Acquir Immune Defic Syndr (2011) 0.84
Subclinical atherosclerosis and subsequent cognitive function. Atherosclerosis (2015) 0.82
Systematic review on the efficacy and safety of herbal medicines for vascular dementia. Evid Based Complement Alternat Med (2011) 0.82
Long-term systemic inflammation and cognitive impairment in a population-based cohort. J Am Geriatr Soc (2014) 0.82
Vascular risk factors and dementia: how to move forward? Neurology (2009) 0.82
Structured approach to patients with memory difficulties in family practice. Can Fam Physician (2013) 0.82
Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke? J Am Heart Assoc (2015) 0.81
Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging. Acta Neuropathol Commun (2013) 0.81
Brain in Congenital Heart Disease Across the Lifespan: The Cumulative Burden of Injury. Circulation (2016) 0.81
White Matter Lesions Are Not Related to β-Amyloid Deposition in an Autopsy-Based Study. Curr Gerontol Geriatr Res (2011) 0.81
Medial temporal atrophy and memory dysfunction in poststroke cognitive impairment-no dementia. J Clin Neurol (2012) 0.81
Learning on Jupiter, learning on the Moon: the dark side of the G-force. Effects of gravity changes on neurovascular unit and modulation of learning and memory. Front Behav Neurosci (2012) 0.80
Cardiovascular risk in cognitively preserved elderlies is associated with glucose hypometabolism in the posterior cingulate cortex and precuneus regardless of brain atrophy and apolipoprotein gene variations. Age (Dordr) (2012) 0.80
Paeoniflorin improves regional cerebral blood flow and suppresses inflammatory factors in the hippocampus of rats with vascular dementia. Chin J Integr Med (2015) 0.80
Central nervous system delivery of large molecules: challenges and new frontiers for intrathecally administered therapeutics. Expert Opin Drug Deliv (2010) 0.80
Vascular disease and risk factors are associated with cognitive decline in the alzheimer disease spectrum. Alzheimer Dis Assoc Disord (2015) 0.79
Lipofuscin hypothesis of Alzheimer's disease. Dement Geriatr Cogn Dis Extra (2011) 0.79
Impaired cognitive executive dysfunction in adult treated hypertensives with a confirmed diagnosis of poorly controlled blood pressure. Int J Med Sci (2014) 0.79
Alterations of the cerebral cortex in sporadic small vessel disease: A systematic review of in vivo MRI data. J Cereb Blood Flow Metab (2016) 0.78
Cardiovascular prevention of cognitive decline. Cardiol Res Pract (2011) 0.78
Impact of white matter lesions on cognition in stroke patients free from pre-stroke cognitive impairment: a one-year follow-up study. Dement Geriatr Cogn Dis Extra (2012) 0.78
Mechanisms of brain aging regulation by insulin: implications for neurodegeneration in late-onset Alzheimer's disease. ISRN Neurol (2011) 0.78
Interaction between therapeutic interventions for Alzheimer's disease and physiological Aβ clearance mechanisms. Front Aging Neurosci (2015) 0.78
Antibodies against phosphorylcholine are not altered in plasma of patients with Alzheimer's disease. BMC Neurol (2015) 0.77
Primary prevention of Alzheimer's disease: is it an attainable goal? J Korean Med Sci (2014) 0.77
Position paper of the Italian Society for the study of Dementias (SINDEM) on the proposal of a new lexicon on Alzheimer disease. Neurol Sci (2011) 0.77
Genetic Risk Factors for Ischemic and Hemorrhagic Stroke. Curr Cardiol Rep (2016) 0.76
Role of Vascular Disease in Alzheimer-Like Progressive Cognitive Impairment. Stroke (2015) 0.76
Extracellular vesicle protein levels are related to brain atrophy and cerebral white matter lesions in patients with manifest vascular disease: the SMART-MR study. BMJ Open (2014) 0.76
Very old adults with better memory function have higher low-density lipoprotein cholesterol levels and lower triglyceride to high-density lipoprotein cholesterol ratios: KOCOA Project. J Alzheimers Dis (2013) 0.76
Estimating the prevalence of dementia using multiple linked administrative health records and capture-recapture methodology. Emerg Themes Epidemiol (2017) 0.75
The Influence of Vascular Risk Factors and Stroke on Cognition in Late Life: Analysis of the NACC Cohort. Alzheimer Dis Assoc Disord (2015) 0.75
Framingham Coronary Heart Disease Risk Score Can be Predicted from Structural Brain Images in Elderly Subjects. Front Aging Neurosci (2014) 0.75
Alzheimer's disease and infections, where we stand and where we go. Immun Ageing (2014) 0.75
Time, Sex, Gender, History, and Dementia. Alzheimer Dis Assoc Disord (2017) 0.75
Isometric Exercise Training for Managing Vascular Risk Factors in Mild Cognitive Impairment and Alzheimer's Disease. Front Aging Neurosci (2017) 0.75
Impact of Physical Activity on Cognitive Decline, Dementia, and Its Subtypes: Meta-Analysis of Prospective Studies. Biomed Res Int (2017) 0.75
Differential associations of plasma lipids with incident dementia and dementia subtypes in the 3C Study: A longitudinal, population-based prospective cohort study. PLoS Med (2017) 0.75
Brain microvascular injury and white matter disease provoked by diabetes-associated hyperamylinemia. Ann Neurol (2017) 0.75
A brief update on dementia prevention. Z Gerontol Geriatr (2012) 0.75
Carotid atherosclerosis promotes the progression of Alzheimer's disease: A three-year prospective study. Exp Ther Med (2017) 0.75
Inhibited Expression of α4β2 Nicotinic Acetylcholine Receptor in Blood Leukocytes of Chinese Patients with Vascular Dementia and in Blood Leukocytes as Well as the Hippocampus of Brain from Ischemic Rats. Cell Mol Neurobiol (2016) 0.75
Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology (1984) 119.59
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology (1991) 23.01
Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology (1993) 16.92
Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA (1997) 10.75
Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med (2003) 10.61
Forecasting the global burden of Alzheimer's disease. Alzheimers Dement (2007) 10.01
Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke (1996) 7.81
15-year longitudinal study of blood pressure and dementia. Lancet (1996) 6.44
Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet (1998) 6.20
Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology (1992) 5.95
Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ (2001) 5.40
Lacunar strokes and infarcts: a review. Neurology (1982) 5.39
Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann Neurol (2000) 5.34
Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomised trial. Lancet (2002) 5.05
Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study. Lancet (1997) 5.04
The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial. J Hypertens (2003) 4.91
The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol (2005) 4.54
Midlife blood pressure and dementia: the Honolulu-Asia aging study. Neurobiol Aging (2000) 4.22
Aggregation of vascular risk factors and risk of incident Alzheimer disease. Neurology (2005) 4.04
The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study. Arch Intern Med (2002) 3.61
Dementia after stroke: the Framingham Study. Stroke (2004) 3.53
Stroke and the risk of Alzheimer disease. Arch Neurol (2003) 3.49
Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol (2001) 3.43
Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL. Lancet Neurol (2008) 3.41
Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study. Stroke (2002) 3.05
Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease. Arch Intern Med (2003) 3.02
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation (2005) 2.97
Cognition and diabetes: a lifespan perspective. Lancet Neurol (2008) 2.96
Subcortical infarcts, Alzheimer's disease pathology, and memory function in older persons. Ann Neurol (2007) 2.66
Cognitive impact of subcortical vascular and Alzheimer's disease pathology. Ann Neurol (2006) 2.62
Silent MRI infarcts and the risk of future stroke: the cardiovascular health study. Neurology (2001) 2.55
Risk estimates of dementia by apolipoprotein E genotypes from a population-based incidence study: the Rotterdam Study. Arch Neurol (1998) 2.53
Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch Neurol (2000) 2.37
The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology (1997) 2.31
Efficacy and tolerability of donepezil in vascular dementia: positive results of a 24-week, multicenter, international, randomized, placebo-controlled clinical trial. Stroke (2003) 2.19
Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease. Lancet (1999) 2.11
Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology (1998) 2.09
Vascular factors predict rate of progression in Alzheimer disease. Neurology (2007) 2.06
Mixed dementia: emerging concepts and therapeutic implications. JAMA (2004) 1.82
Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease. BMC Med (2007) 1.72
A follow-up study of blood pressure and cerebral white matter lesions. Ann Neurol (1999) 1.67
Cerebral microhemorrhage. Stroke (2006) 1.58
Efficacy and safety of memantine in patients with mild to moderate vascular dementia: a randomized, placebo-controlled trial (MMM 300). Stroke (2002) 1.57
Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology (2003) 1.53
White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke (2004) 1.26
Cerebral infarcts in patients with autopsy-proven Alzheimer's disease: CERAD, part XVIII. Consortium to Establish a Registry for Alzheimer's Disease. Neurology (1998) 1.26
Degenerative and vascular lesions of the brain have synergistic effects in dementia of the elderly. Acta Neuropathol (2002) 1.19
Progression of cerebral white matter hyperintensities on MRI is related to diastolic blood pressure. Neurology (1998) 1.11
Dementia and cerebrovascular disease. Mayo Clin Proc (2006) 1.04
Less atherosclerosis and lower blood pressure for a meaningful life perspective with more brain. Hypertension (2007) 1.02
Understanding the pathology of vascular cognitive impairment. J Neurol Sci (2004) 0.90
Risk factors for lacunar stroke: a case-control transesophageal echocardiographic study. Neurology (2000) 0.85
Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet (2009) 14.86
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA (2010) 9.52
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease. Nat Genet (2011) 9.23
Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project. Am J Epidemiol (2011) 8.00
High-resolution whole-genome association study of Parkinson disease. Am J Hum Genet (2005) 6.86
Generalizability of epidemiological findings and public health decisions: an illustration from the Rochester Epidemiology Project. Mayo Clin Proc (2012) 6.21
The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology (2008) 5.94
Data resource profile: the Rochester Epidemiology Project (REP) medical records-linkage system. Int J Epidemiol (2012) 4.47
An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease. Ann Neurol (2012) 4.36
Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease. JAMA (2006) 4.26
Identification of common variants associated with human hippocampal and intracranial volumes. Nat Genet (2012) 3.73
Why patients visit their doctors: assessing the most prevalent conditions in a defined American population. Mayo Clin Proc (2013) 3.40
Relationship between blood pressure and outdoor temperature in a large sample of elderly individuals: the Three-City study. Arch Intern Med (2009) 3.38
A genomic pathway approach to a complex disease: axon guidance and Parkinson disease. PLoS Genet (2007) 3.28
Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy. Circulation (2005) 2.97
Higher risk of progression to dementia in mild cognitive impairment cases who revert to normal. Neurology (2013) 2.73
Migraine and risk of haemorrhagic stroke in women: prospective cohort study. BMJ (2010) 2.63
Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. BMJ (2009) 2.62
Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol (2007) 2.53
Assessing the temporal relationship between cognition and gait: slow gait predicts cognitive decline in the Mayo Clinic Study of Aging. J Gerontol A Biol Sci Med Sci (2012) 2.48
When does Parkinson disease start? Arch Neurol (2010) 2.41
Prevalence of neuropsychiatric symptoms in mild cognitive impairment and normal cognitive aging: population-based study. Arch Gen Psychiatry (2008) 2.39
Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium. Ann Neurol (2011) 2.37
Premature menopause or early menopause: long-term health consequences. Maturitas (2009) 2.33
Prophylactic oophorectomy in premenopausal women and long-term health. Menopause Int (2008) 2.26
Genome-wide association study confirms BST1 and suggests a locus on 12q24 as the risk loci for Parkinson's disease in the European population. Hum Mol Genet (2010) 2.21
Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol (2006) 2.13
Incidence of dementia among participants and nonparticipants in a longitudinal study of cognitive aging. Am J Epidemiol (2014) 2.09
Association of duration and severity of diabetes mellitus with mild cognitive impairment. Arch Neurol (2008) 2.04
CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease. Ann Neurol (2004) 2.03
Validation of the telephone interview for cognitive status-modified in subjects with normal cognition, mild cognitive impairment, or dementia. Neuroepidemiology (2009) 2.03
Physical exercise, aging, and mild cognitive impairment: a population-based study. Arch Neurol (2010) 2.02
Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study. Stroke (2010) 1.91
Increased cardiovascular mortality after early bilateral oophorectomy. Menopause (2009) 1.89
Cognitive impairment improves the predictive validity of the phenotype of frailty for adverse health outcomes: the three-city study. J Am Geriatr Soc (2009) 1.87
Risk tables for parkinsonism and Parkinson's disease. J Clin Epidemiol (2002) 1.86
Relationship between blood pressure and depression in the elderly. The Three-City Study. J Hypertens (2008) 1.79
Common variants at 12q14 and 12q24 are associated with hippocampal volume. Nat Genet (2012) 1.79
Antithrombotic therapy and bleeding risk in a prospective cohort study of patients with cerebral cavernous malformations. Stroke (2012) 1.77
Age- and sex-related effects on the neuroanatomy of healthy elderly. Neuroimage (2005) 1.75
Epidemiology and prognostic significance of chronic kidney disease in the elderly--the Three-City prospective cohort study. Nephrol Dial Transplant (2011) 1.74
Comorbid conditions associated with Parkinson's disease: a population-based study. Mov Disord (2006) 1.73
Unhealthy behaviours and disability in older adults: three-City Dijon cohort study. BMJ (2013) 1.70
Mild cognitive impairment due to Alzheimer disease in the community. Ann Neurol (2013) 1.68
Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis. J Alzheimers Dis (2010) 1.65
Survival study of Parkinson disease in Olmsted County, Minnesota. Arch Neurol (2003) 1.63
A cross-sectional and longitudinal study of the relationship between walking speed and cognitive function in community-dwelling elderly people. J Gerontol A Biol Sci Med Sci (2009) 1.61
Dementia and Alzheimer disease incidence rates do not vary by sex in Rochester, Minn. Arch Neurol (2002) 1.58
Fracture risk after the diagnosis of Parkinson's disease: Influence of concomitant dementia. Mov Disord (2006) 1.58
Professional exposure to pesticides and Parkinson disease. Ann Neurol (2009) 1.56
Homocysteine, white matter hyperintensities, and cognition in healthy elderly people. Ann Neurol (2003) 1.55
UCHL1 is a Parkinson's disease susceptibility gene. Ann Neurol (2004) 1.54
Using RxNorm and NDF-RT to classify medication data extracted from electronic health records: experiences from the Rochester Epidemiology Project. AMIA Annu Symp Proc (2011) 1.54
Metabolic syndrome and risk for incident Alzheimer's disease or vascular dementia: the Three-City Study. Diabetes Care (2008) 1.52
Headache, migraine, and structural brain lesions and function: population based Epidemiology of Vascular Ageing-MRI study. BMJ (2011) 1.51
Genome-wide association studies of MRI-defined brain infarcts: meta-analysis from the CHARGE Consortium. Stroke (2009) 1.47
Effects of perindopril-based lowering of blood pressure on intracerebral hemorrhage related to amyloid angiopathy: the PROGRESS trial. Stroke (2009) 1.43
Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ (2010) 1.43
Incidence, time trends, laterality, indications, and pathological findings of unilateral oophorectomy before menopause. Menopause (2014) 1.42
Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc (2006) 1.42
Cardiovascular risk factors and diseases in women undergoing hysterectomy with ovarian conservation. Menopause (2016) 1.41
Age and sex patterns of drug prescribing in a defined American population. Mayo Clin Proc (2013) 1.38
Excessive daytime sleepiness is an independent risk indicator for cardiovascular mortality in community-dwelling elderly: the three city study. Stroke (2009) 1.38
Nonfatal cancer preceding Parkinson's disease: a case-control study. Epidemiology (2002) 1.36
Prevalence, awareness, treatment, and control of hypertension in the elderly: the Three City study. J Hypertens (2006) 1.34
Incidence and pathology of synucleinopathies and tauopathies related to parkinsonism. JAMA Neurol (2013) 1.32
Antihypertensive treatment and change in blood pressure are associated with the progression of white matter lesion volumes: the Three-City (3C)-Dijon Magnetic Resonance Imaging Study. Circulation (2011) 1.32
White matter lesions volume and motor performances in the elderly. Ann Neurol (2009) 1.29
Common carotid artery intima-media thickness, carotid plaques, and walking speed. Stroke (2005) 1.29
Severe cerebral white matter hyperintensities predict severe cognitive decline in patients with cerebrovascular disease history. Stroke (2009) 1.27
No epsilon4 gene dose effect on hippocampal atrophy in a large MRI database of healthy elderly subjects. Neuroimage (2004) 1.26
Vascular dementia in a population-based autopsy study. Arch Neurol (2003) 1.25
Do we really know the cause of death of the very old? Comparison between official mortality statistics and cohort study classification. Eur J Epidemiol (2009) 1.25
Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case-control study. Hum Mol Genet (2003) 1.23
Anxious personality predicts an increased risk of Parkinson's disease. Mov Disord (2010) 1.22
Cerebral white matter lesions are associated with the risk of stroke but not with other vascular events: the 3-City Dijon Study. Stroke (2009) 1.21
Chemical exposures and Parkinson's disease: a population-based case-control study. Mov Disord (2006) 1.20
An automated procedure for the assessment of white matter hyperintensities by multispectral (T1, T2, PD) MRI and an evaluation of its between-centre reproducibility based on two large community databases. Neuroradiology (2007) 1.20
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study. Pharmacoepidemiol Drug Saf (2009) 1.20
Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2. Alzheimers Dement (2011) 1.19
Effects of ApoE-epsilon4 allele load and age on the rates of grey matter and hippocampal volumes loss in a longitudinal cohort of 1186 healthy elderly persons. Neuroimage (2010) 1.19
The CALHM1 P86L polymorphism is a genetic modifier of age at onset in Alzheimer's disease: a meta-analysis study. J Alzheimers Dis (2010) 1.19
White matter lesions as a predictor of depression in the elderly: the 3C-Dijon study. Biol Psychiatry (2007) 1.17
Complex segregation analysis of Parkinson's disease: The Mayo Clinic Family Study. Ann Neurol (2006) 1.16
Baseline neuropsychiatric symptoms and the risk of incident mild cognitive impairment: a population-based study. Am J Psychiatry (2014) 1.16
APOE genotype and MRI markers of cerebrovascular disease: systematic review and meta-analysis. Neurology (2013) 1.14
Reliability of self-reported ancestry among siblings: implications for genetic association studies. Am J Epidemiol (2006) 1.14
Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol (2013) 1.11
Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging. Arch Neurol (2012) 1.11
Association of type 2 diabetes with brain atrophy and cognitive impairment. Neurology (2014) 1.10
Late-life depression and mortality: influence of gender and antidepressant use. Br J Psychiatry (2008) 1.10
Carotid intima-media thickness in plaque-free site, carotid plaques and coronary heart disease risk prediction in older adults. The Three-City Study. Atherosclerosis (2011) 1.10
Risk of cancer after the diagnosis of Parkinson's disease: a historical cohort study. Mov Disord (2005) 1.09
Association between Parkinson's disease and the HLA-DRB1 locus. Mov Disord (2012) 1.09
Parkinson's disease in Africa: A systematic review of epidemiologic and genetic studies. Mov Disord (2006) 1.08
High degree of dilated Virchow-Robin spaces on MRI is associated with increased risk of dementia. J Alzheimers Dis (2010) 1.08
Silent brain infarcts: a review of MRI diagnostic criteria. Stroke (2011) 1.08
Heart disease and dementia: a population-based study. Am J Epidemiol (2005) 1.07
Survival study of vascular dementia in Rochester, Minnesota. Arch Neurol (2003) 1.06